4//SEC Filing
Mingozzi Federico 4
Accession 0001609351-19-000064
CIK 0001609351other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:04 PM ET
Size
8.5 KB
Accession
0001609351-19-000064
Insider Transaction Report
Form 4
Mingozzi Federico
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-26+8,375→ 15,390 total - Tax Payment
Common Stock
2019-06-26$102.31/sh−2,775$283,910→ 12,615 total - Exercise/Conversion
Restricted Stock Units
2019-06-26−8,375→ 16,750 total→ Common Stock (8,375 underlying)
Footnotes (3)
- [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics Inc. common stock.
- [F3]On September 29, 2017, the reporting person was granted 33,500 restricted stock units to vest in four equal installments. The second installment vested June 26, 2019, with the remaining two installments vesting annually thereafter. Vested shares will be delivered to the reporting person annually on the vesting date.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
Related Parties
1- filerCIK 0001732126
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:04 PM ET
- Size
- 8.5 KB